Press Releases on August 11, 2020 - EIN Presswire - Press Release Distribution Service

Published on August 11, 2020 - 11:00 GMT

TearClear Raises $22 Million to Advance Multiple Clinical Programs in Development

BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- TearClear has raised $22M in a Series B funding round. The investment will be used to advance multiple clinical programs in development, with two lead candidates in glaucoma paving the way for future indications. …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 11, 2020 - 11:00 GMT

Velocity Receives Positive Drill Results from Obichnik Discovery, Bulgaria

Highlights include: Drill Hole ODD-047: 9.0m @ 2.87 g/t gold VANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Velocity Minerals Ltd. (TSX.V: VLC) (“Velocity” or the “Company”) announces receipt of results for additional drill holes at the …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that its partner Kyorin …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2020

Data readouts for AXO-Lenti-PD and AXO-AAV-GM1 remain on-track for Q4 2020 Completed 3-year manufacturing and supply agreement with Oxford BioMedica for AXO-Lenti-PD Company had $55.5 million of cash and cash equivalents as of June 30, 2020 NEW YORK and …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

FirstCash Announces Commencement of Offering of Senior Notes

FORT WORTH, Texas , Aug. 11, 2020 (GLOBE NEWSWIRE) -- FirstCash, Inc. (the “Company”) (Nasdaq: FCFS) today announced that it has commenced an offering through a private placement, subject to market and other conditions, of $400,000,000 in aggregate …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the ...

WEST CHESTER, Pa., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the Company has …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 11, 2020 - 11:00 GMT

FibroGen Announces First Patient Enrolled in Pamrevlumab Phase 3 Clinical Trial in Patients with Duchenne Muscular Dystrophy

SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced the initiation of LELANTOS, a Phase 3, randomized, double-blind, placebo-controlled trial of pamrevlumab or placebo in combination with systemic corticosteroids in …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 11, 2020 - 11:00 GMT

Applied Therapeutics Reports Second Quarter 2020 Financial Results

NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

Fulcrum Therapeutics Announces Interim Analysis Data from its ReDUX4 Trial in Facioscapulohumeral Muscular Dystrophy (FSHD)

Reduction in DUX4-driven gene expression observed in biopsies with highest baseline levels of DUX4-driven gene expression Topline data on-track for Q1 2021 with full data in Q2 2021 Company to review clinical data on second quarter earnings call today at 8 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 11, 2020 - 11:00 GMT

BetterLife Announces Closing of Private Placement

Vancouver, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that it has closed the first tranche of its non-brokered private placement (the "Offering …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 11, 2020 - 11:00 GMT

Global WholeHealth Partners with Healgen Scientific to Sell FDA EUA Authorized SARS-COV-2 IgG/IgM Antibody Whole Blood, Serum and ...

SAN CLEMENTE, CA, Aug. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC PINK: GWHP) announced today that it is authorized to sell FDA EUA Authorized SARS-COV-2 IgG/IgM Antibody Whole Blood, Serum and Plasma Rapid Test. …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 11, 2020 - 11:00 GMT

Lifequest Subsidiary Biopipe Global and Hydros Agritech, Inc. Announce Joint Venture to Market Biopipe’s Onsite 100% Sludge Free ...

RIDGEFIELD PARK, NJ, Aug. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ LIFEQUEST WORLD CORP (LQWC ) subsidiary Biopipe Global, which developed the world’s only highly scalable onsite sludge and chemical free sewage wastewater treatment technology, and …

Distribution channels:

Published on August 11, 2020 - 11:00 GMT

Glory Star New Media Group Holdings Limited Releases Letter to Shareholders on Progress to Date and Future Growth Strategies

Beijing, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Glory Star New Media Group Holdings Limited (NASDAQ: GSMG, GSMGW) (“Glory Star” or the “Company”), a leading mobile and online digital media and entertainment company in China, today released a letter to …

Distribution channels: Business & Economy, Media, Advertising & PR

Published on August 11, 2020 - 10:50 GMT

Golden Minerals Drills 23.4m Grading 5.96 g/t Au at Rodeo Gold Project, Durango, Mexico

GOLDEN, Colo., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Golden Minerals Company (“Golden Minerals”, “Golden” or the “Company”) (NYSE American and TSX: AUMN) today announced it has received positive assay results from the first nine diamond drill holes of its in- …

Distribution channels:

Published on August 11, 2020 - 10:49 GMT

CARIBBEAN G-8 ISLANDS COLLABORATE ON INTRA-REGIONAL TOURISM MARKETING CAMPAIGN

A group of eight neighboring islands have joined together to rethink and re-imagine their tourism marketing strategy in the post-Covid era. CHARLESTOWN, NEVIS, August 11, 2020 /⁨EINPresswire.com⁩/ -- As Caribbean destinations across the region reopen …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on August 11, 2020 - 10:33 GMT

Rong360 Jianpu Technology (NYSE:JT) Big Data Institute: 9 Cities’ First-home Mortgage Rates Fell Below 5%

Jianpu Technology (NYSE:JT) BEIJING, CHINA, August 11, 2020 /⁨EINPresswire.com⁩/ -- Ranking: 9 Cities’ First-home Mortgage Rates Fell Below 5%; Harbin Became the Second Lowest City in China In July 2020 (with data in statistics collected from June …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 11, 2020 - 10:30 GMT

Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today reported recent business highlights and second quarter financial results. “ …

Distribution channels:

Published on August 11, 2020 - 10:30 GMT

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate …

Distribution channels:

Published on August 11, 2020 - 10:30 GMT

Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights

Preliminary Data Demonstrates Normalization of CSF GBA1 Enzyme Activity in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease Patients Company Modifies Protocol for PROPEL Trial of PR001 for Parkinson’s Disease Patients with GBA1 …

Distribution channels:

Published on August 11, 2020 - 10:30 GMT

Bilibili to Report Second Quarter 2020 Financial Results on Wednesday, August 26, 2020

SHANGHAI, China, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI), a leading online entertainment platform for young generations in China, today announced that it will report its second quarter 2020 unaudited …

Distribution channels: Media, Advertising & PR, Technology ...